Similar articles for PMID: 25851932

Year	Number of Results
1998	1
2001	1
2002	3
2003	1
2004	5
2005	1
2006	2
2007	2
2008	3
2009	7
2010	12
2011	4
2012	12
2013	9
2014	10
2015	14
2016	9
2017	9
2018	6
2019	5
2020	11
2021	2
2022	4
2023	1
2024	0

1

Ultrasound molecular imaging: Moving toward clinical translation.

Abou-Elkacem L, Bachawal SV, Willmann JK. Abou-Elkacem L, et al. Eur J Radiol. 2015 Sep;84(9):1685-93. doi: 10.1016/j.ejrad.2015.03.016. Epub 2015 Mar 21. Eur J Radiol. 2015. PMID: 25851932 Free PMC article. Review.

2

BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.

Pochon S, Tardy I, Bussat P, Bettinger T, Brochot J, von Wronski M, Passantino L, Schneider M. Pochon S, et al. Invest Radiol. 2010 Feb;45(2):89-95. doi: 10.1097/RLI.0b013e3181c5927c. Invest Radiol. 2010. PMID: 20027118

3

Dynamic contrast enhanced ultrasound for therapy monitoring.

Hudson JM, Williams R, Tremblay-Darveau C, Sheeran PS, Milot L, Bjarnason GA, Burns PN. Hudson JM, et al. Eur J Radiol. 2015 Sep;84(9):1650-7. doi: 10.1016/j.ejrad.2015.05.013. Epub 2015 Jun 28. Eur J Radiol. 2015. PMID: 26231046 Review.

4

Quantitative ultrasound molecular imaging by modeling the binding kinetics of targeted contrast agent.

Turco S, Tardy I, Frinking P, Wijkstra H, Mischi M. Turco S, et al. Phys Med Biol. 2017 Mar 21;62(6):2449-2464. doi: 10.1088/1361-6560/aa5e9a. Epub 2017 Feb 27. Phys Med Biol. 2017. PMID: 28240217

5

Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55.

Tardy I, Pochon S, Theraulaz M, Emmel P, Passantino L, Tranquart F, Schneider M. Tardy I, et al. Invest Radiol. 2010 Oct;45(10):573-8. doi: 10.1097/RLI.0b013e3181ee8b83. Invest Radiol. 2010. PMID: 20808233

6

Molecular Ultrasound Imaging.

Baier J, Rix A, Kiessling F. Baier J, et al. Recent Results Cancer Res. 2020;216:509-531. doi: 10.1007/978-3-030-42618-7_15. Recent Results Cancer Res. 2020. PMID: 32594397 Review.

7

Influence of repetitive contrast agent injections on functional and molecular ultrasound measurements.

Rix A, Palmowski M, Gremse F, Palmowski K, Lederle W, Kiessling F, Bzyl J. Rix A, et al. Ultrasound Med Biol. 2014 Oct;40(10):2468-75. doi: 10.1016/j.ultrasmedbio.2014.04.010. Epub 2014 Jul 9. Ultrasound Med Biol. 2014. PMID: 25023096

8

Ultrasound Molecular Imaging of the Breast Cancer Neovasculature using Engineered Fibronectin Scaffold Ligands: A Novel Class of Targeted Contrast Ultrasound Agent.

Abou-Elkacem L, Wilson KE, Johnson SM, Chowdhury SM, Bachawal S, Hackel BJ, Tian L, Willmann JK. Abou-Elkacem L, et al. Theranostics. 2016 Jun 28;6(11):1740-52. doi: 10.7150/thno.15169. eCollection 2016. Theranostics. 2016. PMID: 27570547 Free PMC article.

9

VEGFR2-Targeted Contrast-Enhanced Ultrasound to Distinguish between Two Anti-Angiogenic Treatments.

Payen T, Dizeux A, Baldini C, Le Guillou-Buffello D, Lamuraglia M, Comperat E, Lucidarme O, Bridal SL. Payen T, et al. Ultrasound Med Biol. 2015 Aug;41(8):2202-11. doi: 10.1016/j.ultrasmedbio.2015.04.010. Epub 2015 May 15. Ultrasound Med Biol. 2015. PMID: 25980323

10

[Molecular ultrasound imaging: Clinical applications].

Rix A, Palmowski M, Kiessling F. Rix A, et al. Radiologe. 2015 Nov;55(11):956-63. doi: 10.1007/s00117-015-0023-4. Radiologe. 2015. PMID: 26438094 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

122 results

Results by year